Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of octreotide on polycystic liver volume.

× No keyword cloud information.

5 in total

1. Somatostatin analog therapy for severe polycystic liver disease: results after 2 years.

Authors: Marie C Hogan; Tetyana V Masyuk; Linda Page; David R Holmes; Xujian Li; Eric J Bergstralh; Maria V Irazabal; Bohyun Kim; Bernard F King; James F Glockner; Nicholas F Larusso; Vicente E Torres
Journal: Nephrol Dial Transplant Date: 2012-07-06 Impact factor: 5.992

Review 2. Isolated polycystic liver disease.

Authors: Qi Qian
Journal: Adv Chronic Kidney Dis Date: 2010-03 Impact factor: 3.620

3. Polycystic Liver Disease: The Benefits of Targeting cAMP.

Authors: Nicholas F Larusso; Tatyana V Masyuk; Marie C Hogan
Journal: Clin Gastroenterol Hepatol Date: 2016-03-10 Impact factor: 11.382

4. Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial.

Authors: Melissa Chrispijn; Joost P H Drenth
Journal: Trials Date: 2011-11-21 Impact factor: 2.279

5. Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease.

Authors: Tom J G Gevers; Melissa Chrispijn; Jack F M Wetzels; Joost P H Drenth
Journal: BMC Nephrol Date: 2012-04-04 Impact factor: 2.388

5 in total